At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 15 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This study looks at a new pathway for prostate magnetic resonance imaging (MRI) scans. It uses scans from hospitals in North Midlands and Derby and Burton to test the pathway. The sponsor is University Hospitals of North Midlands NHS Trust.
Who can take part
- MRI radiographers (scan staff) at University Hospitals of North Midlands or University Hospitals of Derby and Burton with more than 5 years' experience in prostate MRI
- Radiographers who finished online and hands-on study training before the testing phase
- Past (retrospective) data from 800 patients at each hospital who had an MRI scan and then a biopsy
Who may not be able to
- Radiographers who do not do MRI scans
- Radiographers who did not finish the study training before the testing phase
- Scans that are not multi-parametric MRI (mpMRI)
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 1,600
- Started
- 2025-09-23
- Last checked
- 2026-03
Plain English Summary
What is this study?
- • Testing a new treatment for prostate cancer
- • Clinical study - 1,600 participants
- • Prostate cancer is the second most common cancer in men worldwide
Who can take part?
- • Adults
- • Diagnosed with prostate cancer
Where?
- • Stoke-on-Trent - University Hospitals of North Midlands NHS Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Prostate cancer is the second most common cancer in men worldwide. The demand for magnetic resonance imaging (MRI) to diagnose and manage prostate cancer is continually growing. There is, however, a severe global shortage of radiologists who review and make decisions on prostate scans. This shortage causes compromises that are inefficient and negatively affect care provision, patient outcomes, and patient experiences. Two key examples of these compromises are that every patient receives a gadolinium contrast injection during a prostate MRI scan and patients often require multiple imaging appointments. If radiologists' knowledge of making prostate MRI decisions around these compromises could be harnessed and passed to radiographers (who are trained to acquire the MRIs but currently do not review them) with a computerised system to support clinical decision-making, this would have enormous potential to improve the diagnosing and managing prostate cancer.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓MRI radiographers in University Hospitals of North Midlands (UHNM) and or University Hospitals of Derby and Burton...
- ✓Radiographers from UHNM or UHDB who have completed an online and hands on study specific training materials before...
- ✓Retrospective data of 800 patients each from UHNM and UHDB who have had mpMRI and went on to have a biopsy.
Who cannot take part
- ✗Non-MRI radiographers.
- ✗Radiographers who did not completed an online and hands on study specific training materials before the testing phase.
- ✗Non-mpMRI.
See the full criteria
Where Is This Study? (1 UK site)
University Hospitals of North Midlands NHS Trust
Stoke-on-Trent ST4 6QG, United Kingdom
How to Get in Touch
Aviva Ogbolosingha
Sponsor contactCONTACT